These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34103974)

  • 41. Clinical and prognostic significances of cancer stem cell markers in gastric cancer patients: a systematic review and meta-analysis.
    Razmi M; Ghods R; Vafaei S; Sahlolbei M; Saeednejad Zanjani L; Madjd Z
    Cancer Cell Int; 2021 Feb; 21(1):139. PubMed ID: 33639931
    [TBL] [Abstract][Full Text] [Related]  

  • 42.
    Namjan A; Techasen A; Loilome W; Sa-Ngaimwibool P; Jusakul A
    PeerJ; 2020; 8():e10464. PubMed ID: 33344089
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma.
    Sudsarn P; Boonmars T; Ruangjirachuporn W; Namwat N; Loilome W; Sriraj P; Aukkanimart R; Nadchanan W; Jiraporn S
    Pathol Oncol Res; 2016 Jan; 22(1):57-65. PubMed ID: 26277607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alteration of galectin-1 during tumorigenesis of Opisthorchis viverrini infection-induced cholangiocarcinoma and its correlation with clinicopathology.
    Wu Z; Boonmars T; Nagano I; Boonjaraspinyo S; Pinlaor S; Pairojkul C; Chamgramol Y; Takahashi Y
    Tumour Biol; 2012 Aug; 33(4):1169-78. PubMed ID: 22373585
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Helicobacter pylori GroEL Seropositivity Is Associated with an Increased Risk of Opisthorchis viverrini-Associated Hepatobiliary Abnormalities and Cholangiocarcinoma.
    Jala I; Almanfaluthi ML; Laha T; Kanthawong S; Tangkawattana S; Saichua P; Suttiprapa S; Sripa B
    Korean J Parasitol; 2021 Aug; 59(4):363-368. PubMed ID: 34470087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot study.
    Matuschek C; Lehnhardt M; Gerber PA; Poremba C; Hamilton J; Lammering G; Orth K; Budach W; Bojar H; Bölke E; Peiper M
    Eur J Med Res; 2014 Feb; 19(1):6. PubMed ID: 24491153
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opisthorchiasis-Induced Cholangiocarcinoma: How Innate Immunity May Cause Cancer.
    Edwards SW; Spofford EM; Price C; Wright HL; Salao K; Suttiprapa S; Sripa B
    Adv Parasitol; 2018; 101():149-176. PubMed ID: 29907253
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating TGF-β1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma.
    Kimawaha P; Jusakul A; Junsawang P; Loilome W; Khuntikeo N; Techasen A
    J Gastrointest Oncol; 2020 Apr; 11(2):304-318. PubMed ID: 32399272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients.
    Chamadol N; Pairojkul C; Khuntikeo N; Laopaiboon V; Loilome W; Sithithaworn P; Yongvanit P
    J Hepatobiliary Pancreat Sci; 2014 May; 21(5):316-22. PubMed ID: 24420706
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preoperative Serum Platelet-Lymphocyte Ratio as a Prognostic Factor in Cholangiocarcinoma Patients after Radical Resection: A Retrospective Analysis of 119 Patients.
    Wu Y; Zhou D; Zhang G; Yi F; Feng L
    Gastroenterol Res Pract; 2019; 2019():8506967. PubMed ID: 30809257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticancer Activity of Atractylodes lancea (Thunb.) DC in a Hamster Model and Application of PET-CT for Early Detection and Monitoring Progression of Cholangiocarcinoma.
    Plengsuriyakarn T; Matsuda N; Karbwang J; Viyanant V; Hirayama K; Na-Bangchang K
    Asian Pac J Cancer Prev; 2015; 16(15):6279-84. PubMed ID: 26434829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma.
    Padthaisong S; Thanee M; Namwat N; Phetcharaburanin J; Klanrit P; Khuntikeo N; Titapun A; Loilome W
    BMC Cancer; 2020 Feb; 20(1):154. PubMed ID: 32093644
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Are CD44
    Ryspayeva DE; Smolanka II; Dudnichenko АS; Lyashenko AA; Grinevich YA; Gurianov VG; Koshubarova MV; Seleznev AA
    Exp Oncol; 2017 Sep; 39(3):224-228. PubMed ID: 28967636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting hexokinase II as a possible therapy for cholangiocarcinoma.
    Thamrongwaranggoon U; Seubwai W; Phoomak C; Sangkhamanon S; Cha'on U; Boonmars T; Wongkham S
    Biochem Biophys Res Commun; 2017 Mar; 484(2):409-415. PubMed ID: 28131825
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Ovarian Cancer Patients: Evidence from 52 Studies.
    Tao Y; Li H; Huang R; Mo D; Zeng T; Fang M; Li M
    Cell Physiol Biochem; 2018; 46(4):1716-1726. PubMed ID: 29730663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum antibody response to Opisthorchis viverrini antigen as a marker for opisthorchiasis-associated cholangiocarcinoma.
    Akai PS; Pungpak S; Chaicumpa W; Viroj K; Bunnag D; Befus AD
    Trans R Soc Trop Med Hyg; 1994; 88(4):471-4. PubMed ID: 7570848
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MRI and (1)H MRS findings of hepatobilary changes and cholangiocarcinoma development in hamsters infected with Opisthorchis viverrini and treated with N-nitrosodimethylamine.
    Hanpanich P; Pinlaor S; Charoensuk L; Yongvanit P; Chamgramol Y; Pairojkul C; Mairiang E
    Magn Reson Imaging; 2015 Nov; 33(9):1146-1155. PubMed ID: 26117689
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Levels of 8-OxodG Predict Hepatobiliary Pathology in Opisthorchis viverrini Endemic Settings in Thailand.
    Saichua P; Yakovleva A; Kamamia C; Jariwala AR; Sithithaworn J; Sripa B; Brindley PJ; Laha T; Mairiang E; Pairojkul C; Khuntikeo N; Mulvenna J; Sithithaworn P; Bethony JM
    PLoS Negl Trop Dis; 2015; 9(7):e0003949. PubMed ID: 26230769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Up-regulation of annexin A2 in cholangiocarcinoma caused by Opisthorchis viverrini and its implication as a prognostic marker.
    Yonglitthipagon P; Pairojkul C; Chamgramol Y; Mulvenna J; Sripa B
    Int J Parasitol; 2010 Aug; 40(10):1203-12. PubMed ID: 20493868
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic value of CD44 and CD44v6 expression in patients with non-small cell lung cancer: meta-analysis.
    Jiang H; Zhao W; Shao W
    Tumour Biol; 2014 Aug; 35(8):7383-9. PubMed ID: 24913707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.